Development and evaluation of novel trans- buccoadhesive bilayer tablets of Famotidine

Article Sidebar

PDF
Published: Aug 27, 2014
DOI: https://doi.org/10.22377/ajp.v5i3.100

Main Article Content

M Alagusundaram
C Madhusudhana Chetty
D Dhachinamoorthi

Abstract

The present investigation highlights the novel trans-buccoadhesive tablets of Famotidine, an H2-receptor antagonist used as an antiulcerative agent. The buccoadhesive tablets were prepared by direct compression method using bioadhesive polymers like sodium alginate, SCMC, HPMC-K100M, PVP-K30 either alone or in combinations with EC as a backing layer.The prepared formulations were evaluated for their physicochemical characteristics, swelling index, surface pH, ex vivo buccoadhesive strength, in vitro, in vivo drug release and ex vivo permeation studies. The distinguishable differences in the results were shown to be dependent on characteristics and composition of bioadhesive materials used. Stability studies were performed in natural human saliva and accelerated conditions showed no significant difference in physical appearance, drug
content, buccoadhesive strength and the P-value statistically significant at <0.05. Ex vivo mucous irritation by histological examination reveals, the administration site of buccal tablet over the buccal mucosa did not cause any irritation, ulceration, inflammation and redness, and it resembles to controlled buccal mucosa. Good correlations were observed between in vitro and in vivo drug release, with a correlation coefficient of 0.996. Drug diffusion from buccal tablets showed apparently zero order kinetics and release mechanism was diffusion controlled after considerable swelling.

Downloads

Download data is not yet available.

Article Details

How to Cite
Alagusundaram, M., Chetty, C. M., & Dhachinamoorthi, D. (2014). Development and evaluation of novel trans- buccoadhesive bilayer tablets of Famotidine. Asian Journal of Pharmaceutics (AJP), 5(3). https://doi.org/10.22377/ajp.v5i3.100
Issue
Vol. 5 No. 3 (2011): Jul-Sep
Section
Articles

This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.

References

Goodman and Gilmans. The pharmacological basis of therapeutics. 11th

ed. New York: McGraw Hill Medical Publishing Division; 2006. p. 971-2.

Jaimini M, Rana AC, Tanwar YS. Formulation and evaluation of

famotidine floating tablets. Curr Drug Deliv 2007;4:51-5.

McQuaid KR. Drugs used in the treatment of gastrointestinal diseases.

In: Katzung BG, editor. Basic and clinical pharmacology. 9th ed. Asia:

The McGraw-Hill Companies. Inc; 2004. p. 1036.

Kim TH, Ahn JS, Choi HK, Cho CS. A novel mucoadhesive polymer film

composed of carbopol, poloxamer and hydroxypropylmethylcellulose.

Arch Pharm Res 2007;30:381-6.

Sahni J, Raj S, Ahmad FJ, Khar RK. Design and invitro characterization

of buccoadhesive delivery system of insulin. Indian J Pharm Sci

;70:61-5.

Semalty A, Semalty M, Singh R, Saraf SK, Saraf S. Properties and

formulation of oral drug delivery of protein and peptides. Indian J

Pharm Sci 2007;69:741-7.

The United States Pharmacopeia, 29th Ed. and The National Formulary24th ed. The United States Pharmacopeial Convention Rockville, MD,prepared by the council of experts and published by the Board of

Trustee printed in Canada by Webcom Limited. Toronto; 2005. p.

-9.

Samani SM, Najafi R, Yousefi G. Formulation and in vitro evaluation of

prednisolone buccoadhesive tablets. Farmaco 2005;60:339-44.

Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive buccal

patches of miconazole nitrate – in vitro/in vivo performance and effect

of ageing. Int J Pharm 2003;264:1-14.

Desai KG, Kumar TM. Preparation and evaluation of a Novel Buccal

adhesive system. AAPS Pharm Sci Tech 2004;5:1-9.

Pramod Kumar TM, Shivakumar HG, Desai KG. Oral transmucosal drug

delivery systems. Indian Drugs 2004;41:63-72.

Patl VM, Prajapati BG, Patel MM. Formulation, evaluation and

comparison of bilayered and multilayered mucoadhesive buccal devices

of Propranolol hydrochloride. AAPS Pharm Sci Tech 2007;8:E1-8.

Sahini J, Raj S, Ahmad F, Khar RK. Design and in vitro characterization

of buccoadhesive drug delivery system of insulin. Indian J Pharm Sci

;70:61-5.

Singh B, Ahuja N. Development of controlled release buccoadhesive

hydrophilic matrices of diltiazem hydrochloride: Optimization of

bioadhesion, dissolution and diffusion parameters. Drug Dev Ind

Pharm 2002;28:431-42.

Miyazaki S, Kawasaki N, Nakamura T, Iwatsu M, Hayashi T, Hou WM,

et al. Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and

in vivo evaluation. Int J Pharm 2000;204: 127-32.

Ribeiro L, Ferreira DC, Veiga FJ. In vitro controlled release of

vinpocetine–cyclodextrin–tartaric acid multicomponent complexes

from HPMC swellable tablets. J Control Release 2005;103:325-39.

Shanker G, Kumar CK, Gonugunta CS, Kumar BV, Veerareddy PR.

Formulation and evaluation of bioadhesive buccal drug delivery of

tizanidine hydrochloride tablets. AAPS Pharmscitech 2009;10:530-9.

Giannola LI, De Caro V, Giandalia G, Siragusa MG, Tripodo C, Florena

AM, et al. Release of Naltrexone on buccal mucosa: Permeation studies,

histological aspects and matrix system design. Eur J Pharm Biopharm

;67:425-33.

Shin SC, Bum JP, Choi JS, Enhanced bioavailability by buccal

administration of Triamcinolone Acetonide from the bioadhesive gels

in rabbits. Int J Pharm 2000;209:37-43.

Nakhat PD, Kondawar AA, Babla IB, Rathi LG, Yeole PG. Studies on

buccoadhesive tablets of terbutaline sulphate. Indian J Pharm Sci

;69:505-10.